Here’s a money move for your next coffee break: AbbVie, the pharma giant behind Humira, just got a big thumbs-up from Wall Street. While tech stocks have been hogging the spotlight, AbbVie quietly hiked its dividend for 13 years straight and now pays a 2.9% yield. With new drugs picking up the slack, it’s a solid pick for anyone looking to turn their investments into a steady retirement paycheck. Sometimes, boring is beautiful! #Business #Industry #DividendStocks